Inogen vs Procept Biorobotics
Inogen and Procept Biorobotics are similar in size: $349m and $308m of revenue in their latest fiscal years. Procept Biorobotics grew faster (37.2% against 3.9%). Inogen kept more of each dollar of sales as profit: a net margin of -6.5% against -31.0%. Inogen carries less debt relative to equity (0.0% against 14.2%).
| Latest fiscal year | InogenINGN, 2025 | Procept BioroboticsPRCT, 2025 |
|---|---|---|
| Revenue | $349m | $308m |
| Revenue growth | 3.9% | 37.2% |
| Net income | −$22.7m | −$95.6m |
| Operating margin | -8.7% | -33.7% |
| Net margin | -6.5% | -31.0% |
| Return on equity | -12.4% | -24.9% |
| Free cash flow | −$13.7m | −$58.3m |
| Cash | $104m | $287m |
| Total debt | $0 | $52.0m |
| Debt to equity | 0.0% | 14.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 888 |
| Market value | $186m | $1.16bn |
| Price vs our value range | — | — |
| Moat score | 41 (Weak) | 25 (Weak) |
| Insider trades, 12 months | 0 buys, 2 sales | 8 buys, 14 sales |